|
Researchers Create New Organic Gel Nanomaterials
Troy, N.Y. — Researchers have created organic gel
nanomaterials that could be used to encapsulate pharmaceutical,
food, and cosmetic products and to build 3-D biological
scaffolds for tissue engineering. Using olive oil and six other
liquid solvents, the scientists added a simple enzyme to
chemically activate a sugar that changed the liquids to organic
gels.

Scanning electron microscope images show
organogel fibers in ethyl acetate (top) and
self-supporting organogel scaffold after UV
polymerization in ethyl acetate (bottom).
Photo by Rensselaer/Dordick
|
“We are using the building blocks provided by nature to
create new nanomaterials that are completely reversible and
environmentally benign,” said Jonathan Dordick, the
Howard P. Isermann ‘42 Professor of Chemical and Biological
Engineering at Rensselaer Polytechnic Institute. “The
importance of this finding is the ability to use the same
naturally occurring enzyme both to create chemically functional
organogels and to reverse the process and break down these gels
into their biologically compatible building blocks.”
In the experiments, researchers activated a sugar using a
simple enzyme, which generated a compound that self-assembles
into 3-D fibers measuring approximately 50 nanometers in
diameter. As the fibers entangle, a large amount of solvent
gets packed together, trapping some 10,000 molecules.
The resulting organogel materials could be used as
biocompatible scaffolds for tissue engineering and designing
membranes, according to Dordick. Other possible applications
include delivery systems for pharmaceuticals and preservatives
for food and cosmetics.
“The development of new materials that are molecularly
defined and chemically functional at the nanoscale is of
critical importance to biological applications such as drug
delivery,” said Dordick. “We are finding the natural world has
provided tools to create these materials without the need to
generate new compounds that may be harmful to the body or
environment.”
The findings are currently available online in advance of
print publication July 17 by the journal Angewandte
Chemie.
Dordick’s research involves using enzyme technology to
produce unique chemical structures with applications in drug
discovery, materials science, and chemical
technology.
The research is led by Dordick and includes George John of
the City University of New York; Guangyu Zhu, post-doctoral
research associate at Rensselaer; and Jun Li of the University
of Southern Mississippi. The paper is titled “Enzymatically
Derived Sugar-Containing Self-Assembled Organogels with
Nanostructured Morphologies.”
The funding for this research was provided by the National
Science Foundation-funded Nanoscale Science and Engineering
Center (NSEC) at Rensselaer, the Center for Directed Assembly
of Nanostructures.
Nanotechnology at Rensselaer
In September 2001, the National Science Foundation
selected Rensselaer as one of the six original sites for a new
Nanoscale Science and Engineering Center (NSEC). As part of the
U.S. National Nanotechnology Initiative, the program is housed
within the Rensselaer Nanotechnology Center and forms a
partnership between Rensselaer, the University of Illinois at
Urbana-Champaign, and Los Alamos National Laboratory. The
mission of Rensselaer’s Center for Directed Assembly of
Nanostructures is to integrate research, education, and
technology dissemination, and to serve as a national resource
for fundamental knowledge in directed assembly of
nanostructures. The five other original NSECs are located at
Harvard University, Columbia University, Cornell University,
Northwestern University, and Rice University.
Biotechnology and Interdisciplinary Studies at
Rensselaer
At Rensselaer, faculty and students in diverse
academic and research disciplines are collaborating at the
intersection of the life sciences and engineering to encourage
discovery and innovation. Rensselaer’s four biotechnology
research constellations - biocatalysis and metabolic
engineering, functional tissue engineering and regenerative
medicine, biocomputation and bioinformatics, and integrative
systems biology - engage a multidisciplinary mix of faculty and
students focused on the application of engineering and physical
and information sciences to the life sciences. Ranked among the
world’s most advanced research facilities, the Center for
Biotechnology and Interdisciplinary Studies at Rensselaer
provides a state-of-the-art platform for collaborative research
and world-class programs and symposia.
|
Published
June 28,
2006 |
Contact: Tiffany Lohwater
Phone: (518) 276-6542
E-mail: lohwat@rpi.edu |
|